June 2012 - Volume 19 - Issue 6
pp: 597-711

Evolution of postmenopausal hormone therapy between 2002 and 2009

Ettinger, Bruce; Wang, Sharon M.; Leslie, R. Scott; More

Menopause. 19(6):610-615, June 2012.

  • Editorial

A decade of postmenopausal hormone therapy prescribing in the United States: long-term effects of the Women’s Health Initiative

Steinkellner, Amy R.; Denison, Shannon E.; Eldridge, Sandra L.; More

Menopause. 19(6):616-621, June 2012.

  • Editorial

Transdermal estradiol gel for the treatment of symptomatic postmenopausal women

Archer, David F.; Pickar, James H.; MacAllister, Dipali C.; More

Menopause. 19(6):622-629, June 2012.

  • Editorial

Systemic and topical hormone therapies reduce vaginal innervation density in postmenopausal women

Griebling, Tomas L.; Liao, Zhaohui; Smith, Peter G.

Menopause. 19(6):630-635, June 2012.

  • Editorial

Association between cognitive impairment and bone mineral density in postmenopausal women

Lee, Dong-Yun; Na, Duk L.; Seo, Sang Won; More

Menopause. 19(6):636-641, June 2012.

  • Editorial

Relationship between bone turnover biomarkers, mandibular bone mineral density, and systemic skeletal bone mineral density in premenopausal and postmenopausal Indian women

Makker, Annu; Singh, Man Mohan; Mishra, Geetanjali; More

Menopause. 19(6):642-649, June 2012.

  • Editorial

Androstenediol complements estrogenic bioactivity during the menopausal transition

Lasley, Bill L.; Chen, Jiangang; Stanczyk, Frank Z.; More

Menopause. 19(6):650-657, June 2012.

Menopausal transition stage–specific changes in circulating adrenal androgens

McConnell, Daniel S.; Stanczyk, Frank Z.; Sowers, MaryFran R.; More

Menopause. 19(6):658-663, June 2012.